Science Explorer Back to mapMap
Discussion
Researcher · Simcere Pharmaceutical (China) · China

Liting Xue

Liting Xue publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Protein Degradation and Inhibitors, Angiogenesis and VEGF in Cancer and Acute Myeloid Leukemia Research.

ORCID 0000-0002-5277-4433 OpenAlex
World rank
#3,285,447
of 7,710,434 ranked researchers
Rank in China
#516,179
of 978,568
Works
78
Citations
576
Citations per work
7.4
h-index
9
i10-index 9Top 82% in Molecular Biology
Liting Xue

What does Liting Xue research?

Liting Xue's work is mostly in Biochemistry, Genetics and Molecular Biology (50%), Medicine (25%).

Life Sciences: 39 works · 50.2% of their workBiochemistry, Genetics and Molecular Biology: 39 works · 50.2% of their workMolecular Biology: 32 works · 41.4% of their workCancer Research: 4 works · 4.7% of their workGenetics: 3 works · 4.1% of their workEverything else: 20 works · 25.0% of their workHealth Sciences: 19 works · 24.8% of their workMedicine: 19 works · 24.8% of their workOncology: 10 works · 12.4% of their workPulmonary and Respiratory Medicine: 5 works · 6.5% of their workHematology: 5 works · 5.9% of their workTHEIR WORKLiting Xue78works
Life Sciences50%Health Sciences25%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3950.2%
  2. Everything else2025.0%
    1. Medicine1924.8%
  1. 1Molecular Biology41% of their works
  2. 2Oncology12% of their works
  3. 3Pulmonary and Respiratory Medicine6% of their works
  4. 4Hematology6% of their works
  5. 5Cancer Research5% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Liting Xue's research?

The keywords of their largest research topics: Transcriptional Regulation, Cancer, BET Bromodomains, Breast Cancer, PROTACs, Acute Myeloid Leukemia, AML and endothelial progenitor cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Transcriptional Regulation203 topics
  2. Cancer112 topics
  3. BET Bromodomains101 topic
  4. Breast Cancer102 topics
  5. PROTACs101 topic
  6. AML71 topic
  7. Acute Myeloid Leukemia71 topic
  8. VEGF71 topic
  9. endothelial progenitor cells71 topic
  10. Arginine Methylation61 topic
  11. CDK4/6 Inhibitors61 topic
  12. Palbociclib61 topic
  13. Protein Arginine Methyltransferases61 topic
  14. DNA Damage51 topic
  15. Repair51 topic
  16. Estrogen41 topic
  17. HIF-141 topic
  18. Receptor41 topic
  19. Warburg Effect41 topic

Where does Liting Xue work?

Liting Xue's main affiliation in the publication record is Simcere Pharmaceutical (China), China.

How many publications and citations does Liting Xue have?

OpenAlex counts 78 works and 576 citations for Liting Xue, an h-index of 9, ranking #3,285,447 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Liting Xue. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.